rhPSMA-7.3 (18F) PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhPSMA-7.3 (18F) PET/CT, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance [Phase 2]